Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease

Uwe Rueckschloss; Mark T. Quinn; Juergen Holtz; Henning Morawietz

Arteriosclerosis Thrombosis and Vascular Biology (2002) - Comment
pubmed: 12426214 issn: 1524-4636 doi: 10.1161/01.atv.0000035392.38687.65 issn: 1079-5642

Uwe Rueckschloss, Mark T. Quinn, Juergen Holtz, Henning Morawietz

Go to article
Go to preprint

Ovid Technologies (Wolters Kluwer Health)